Dentsply Int'l (XRAY) Tops Q4 EPS by 2c, Guides Modestly Below the Street
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
Price: $11.38 -0.44%
EPS Growth %: -36.0%
Financial Fact:
Cost of products sold: 440.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -36.0%
Financial Fact:
Cost of products sold: 440.6M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Dentsply Int'l (NASDAQ: XRAY) reported Q4 EPS of $0.67, $0.02 better than the analyst estimate of $0.65. Revenue for the quarter came in at $996.5 million versus the consensus estimate of $1.01 billion.
GUIDANCE:
Dentsply Int'l sees FY2017 EPS of $2.80-$2.90, versus the consensus of $2.94.
For earnings history and earnings-related data on Dentsply Int'l (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Prabhudas Lilladher Upgrades GE Vernova T&D India (GVTD:IN) to Buy (1)
- JPMorgan Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
